Will Coronavirus herald a new era in vaccine innovation?

As this novel coronavirus continues to spread, and the number of people infected with COVID-19 keeps rising, the race is on to develop a vaccine. But the time it takes to carry out clinical trials, to ensure that a vaccine is both safe and effective, means this won’t happen overnight.

However, with at least 35 coronavirus vaccines now being developed, even compared to recent pandemics, we have new tools available that could help us reach that goal in record time.

Read more on the Gavi website here.

You May Also Like

Linked Community News December 2024 / January 2025

Are you interested in exploring barriers, strategies, and country experiences addressing HPV demand generation and vaccine acceptance strategies or developing national Electronic Immunisation Registries (EIR) to improve immunisation outcomes? Keep reading below to find critical resources and uncover key insights to strengthen your national immunisation program. This blog outlines strategies for making national level information … Read More

Linked Community News October/November 2024

This newsletter is available in English, Portuguese, Spanish, and Russian. Are you interested in lessons and country experiences addressing HPV demand generation and vaccine acceptance strategies or designing and managing electronic immunisation registries (EIRs) to improve immunisation outcomes? Read below to find critical resources to learn more about how you can strengthen immunisation programming across … Read More

What is the cost of delivering vaccines through integrated campaigns? Evidence from Nigeria and Sierra Leone

Findings from bottom-up costing studies of integrated vaccination campaigns in Nigeria and Sierra Leone has been published in BMC Health Services Research. The research, conducted by ThinkWell and the University of Nigeria, Nsukka, estimated the costs of a campaign held in 2019 in Sierra Leone with measles-rubella vaccine and oral polio vaccine, during which nutrition … Read More